About CrescentDX
CrescentDX was a Healthcare company based in Belfield (United States) founded in 2011. It develops and markets diagnostic screening tests for osteoporosis. It operates on a B2B model. CrescentDX has raised $2.16 million across 1 funding round from investors including Kernel Capital, Seroba Lifesciences and AIB Seed Capital Fund. The company is recorded as dissolved. Its focus areas include Medical Devices, Diagnostic Testing and Osteoporosis Screening. Its competitors include Imagen, CD Diagnostics and MuscleSound; 3 of its 3 listed competitors have raised funding.
Company details
CrescentDX develops and markets diagnostic screening tests for osteoporosis, focusing on providing healthcare solutions, developing medical devices, diagnostic testing, and osteoporosis screening. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Belfield, United States
- SectorsHealthcare
- Website crescentdx.com
- Social X Facebook
- Total Equity Funding$2.16M (USD)
in 1 rounds
- Latest Funding Round$2.16M (USD), Series A
Jun 2011
- InvestorsKernel Capital
& 2 more
Funding Insights of CrescentDX
CrescentDX has successfully raised a total of $2.16M through 1 strategic funding round. The most recent funding activity was a Series A round of $2.16 million completed in June 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.16M
- Total Rounds 1
- Last Round Series A — $2.16M
- First Round $2.16M
(Jun 2011)
- Investors Count 3
All 1 funding rounds of CrescentDX with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2011 | $2.16M | Series A | – | – |
3 investors in total: 3 institutional.
Investors in CrescentDX
CrescentDX has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Kernel Capital, Seroba Lifesciences and AIB Seed Capital Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VC firm investing in the UK and the US | kernel-capital.com | Cork, Ireland | ||
| aibseedcapitalfund.ie | ||||
Seroba Lifesciences is focused on life sciences venture capital investments. | seroba-lifesciences.com | Dublin, Ireland |
Investor details for CrescentDX
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of CrescentDX
2 dated milestones of CrescentDX, from founding to its latest funding, stage changes and deals.
- Founded CrescentDX is founded.
- Funding First funding round of $2.2M.
Competitors of CrescentDX
CrescentDX has 3 listed competitors in our database, 3 of them funded. They include Imagen, CD Diagnostics and MuscleSound.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| imagen.ai | 2016 | New York, United States | $59.69M | AI solutions for detecting pathologies in medical images are developed. | ||
| cddiagnostics.com | 2008 | Claymont, United States | $6.61M | 56 | Synovial fluid is tested for biomarkers in orthopedic disorders. | |
| musclesound.com | 2011 | Denver, United States | $8.9M | Muscular glycogen levels are measured non-invasively via ultrasound. |
Detailed competitors of CrescentDX
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Hematology
3 companies that operate in the same segment as CrescentDX (Hematology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 300 M | 384 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CrescentDX
CrescentDX was founded in 2011.
CrescentDX is headquartered in Belfield, United States. It is registered at Belfield, North Dakota, United States.
CrescentDX is a funded company, having raised a total of $2.16M across 1 funding round to date. The company's 1st funding round was a Series A of $2.16M, raised on Jun 2011.
CrescentDX develops and markets diagnostic screening tests for osteoporosis, focusing on providing healthcare solutions, developing medical devices, diagnostic testing, and osteoporosis screening. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
CrescentDX's top competitors include CD Diagnostics, Imagen and MuscleSound.
CrescentDX has 3 investors. Key investors include Kernel Capital, Seroba Lifesciences, and AIB Seed Capital Fund.